{
    "medicine_id": "636aefa16f915177f5a8a4510406772dc639b887",
    "platform_id": "DB11853",
    "metadata": {
        "name": "Giapreza 2 5 mg 1mL Injection",
        "composition": "2 5 mg 1mL Relugolix",
        "clinical_particulars": {
            "therapeutic_indications": "Relugolix is indicated for the treatment of adult patients with advanced prostate cancer L27991",
            "contraindications": {
                "disease": "Data regarding overdose of relugolix are unavailable",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Approximately 56 of patients achieved castrate level testosterone concentrations 50 ng dL by day 4 of therapy and 97 of patients maintain these levels through 48 weeks of therapy L27991 Relugolix requires once daily oral administration to maintain the desired testosterone concentrations Androgen deprivation therapies may prolong the QTc interval and should therefore be used with caution in patients having a high baseline risk of QTc prolongation such as those with electrolyte abnormalities congestive heart failure or using other medications known to prolong the QTc interval L27991 Based on its mechanism of action and data from animal studies relugolix may result in fetal harm if administered to pregnant females male patients with female partners should be advised to use effective contraception throughout therapy and for 2 weeks following cessation of therapy to prevent inadvertent fetal exposure L27991",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09277",
                        "description": "Relugolix may decrease effectiveness of Choline C 11 as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB00089",
                        "description": "Relugolix may decrease effectiveness of Capromab pendetide as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Propranolol"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Atropine"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Adenosine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Flecainide"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Azimilide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Indenolol"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Delamanid"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Sotalol"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Astemizole"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Procainamide"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of QTc prolongation can be increased when Esmolol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of QTc prolongation can be increased when Timolol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of QTc prolongation can be increased when Digoxin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of QTc prolongation can be increased when Risperidone is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of QTc prolongation can be increased when Felodipine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxepin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of QTc prolongation can be increased when Desipramine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Eribulin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Flumequine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Famphur is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Fenthion is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Phosmet is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bilastine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Ebastine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The risk or severity of QTc prolongation can be increased when Talinolol is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Cicletanine"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Inotersen"
                    },
                    {
                        "drugbank-id": "DB16019",
                        "description": "Relugolix may increase effectiveness of Gallium Ga 68 gozetotide as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Loxapine"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Simvastatin"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Clofazimine"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Vardenafil"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Conivaptan"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Quinidine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Tipranavir"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB04851",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Biricodar"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04881",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Elacridar"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Telaprevir"
                    },
                    {
                        "drugbank-id": "DB06191",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Zosuquidar"
                    },
                    {
                        "drugbank-id": "DB06240",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Tariquidar"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Simeprevir"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Isavuconazonium"
                    },
                    {
                        "drugbank-id": "DB07348",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Brefeldin A"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Ivacaftor"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Lomitapide"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Afatinib"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Ledipasvir"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Suvorexant"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Netupitant"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Palbociclib"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Daclatasvir"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Venetoclax"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Velpatasvir"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB11672",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Curcumin"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Istradefylline"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Neratinib"
                    },
                    {
                        "drugbank-id": "DB11869",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Valspodar"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Elagolix"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Voxilaprevir"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Sarecycline"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB12466",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Favipiravir"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Fedratinib"
                    },
                    {
                        "drugbank-id": "DB12582",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Piperine"
                    },
                    {
                        "drugbank-id": "DB12799",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Laniquidar"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Pibrentasvir"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Glecaprevir"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14069",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with ONT 093"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Ripretinib"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Pralsetinib"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Pentobarbital"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00648",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Mitotane"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB00896",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Rimexolone"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01201",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Rifapentine"
                    },
                    {
                        "drugbank-id": "DB01220",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Rifaximin"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Levothyroxine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Trazodone"
                    },
                    {
                        "drugbank-id": "DB06414",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Etravirine"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The serum concentration of Relugolix can be decreased when it is combined with Prednisolone phosphate"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}